New Delhi [India], October 9 (ANI): Pharma Industry revenue growth is likely to grow by 8.5 per cent (YoY) and will be driven by domestic formulations and niche launches in the US market, according to a report by Axis Securities. The report says companies within the coverage are anticipated to post a collective revenue growth […]
Pharma Industry growth will be driven by domestic formulations and niche launches in US market: Report
